B4559

BRL 44408

≥98% (HPLC)

• Synonym(e): 2-[2H-(1-Methyl-1,3-dihydroisoindol)-methyl]-4,5-dihydroimidazol -maleat (Salz)
• Empirische Formel (Hill-System): C₁₇H₂₁N₃O₄
• CAS-Nummer: 118343-19-4
• Molekulargewicht: 331.37
• NACRES: NA.77
• PubChem Substance ID: 329773239
• UNSPSC Code: 12352200
• MDL number: MFCD02262218
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: H₂O: soluble 15 mg/mL, clear
• originator: GlaxoSmithKline
• SMILES string: OC(=O)\C=C/C(O)=O.CC1N(CC2=NCCN2)Cc3ccccc13
• InChI: 1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1-
• InChI key: DDIQGSUEJOOQQQ-BTJKTKAUSA-N

Beschreibung

Biochem/physiol Actions

Selektiver α_2A-Adrenoceptor-Antagonist

Features and Benefits

This compound is featured on the α2-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Wird in Vereinbarung mit Glaxo­Smith­Kline verkauft.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)